FdaApplication
ANDA 215709
Identifiers
- fda_app_no: ANDA215709
Properties
| Property | Value |
|---|---|
| applicant_name | NEXUS PHARMACEUTICALS LLC |
| application_type | ANDA |
| approval_date | 2023-09-25 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| FLUORESCEIN SODIUM | FLUORESCEIN SODIUM | EQ 500MG BASE/5ML (EQ 100MG BASE/ML) | INJECTABLE;INTRAVENOUS |
| FLUORESCEIN SODIUM | FLUORESCEIN SODIUM | EQ 500MG BASE/2ML (EQ 250MG BASE/ML) | INJECTABLE;INTRAVENOUS |
2 products